(Q44061378)

29 November 2017

title

Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir (English)

1 reference

29 November 2017

1 reference

Takeshi Honda

1

1 reference

29 November 2017

Takeshi Masuda

2

1 reference

29 November 2017

Shuku Yoshida

3

1 reference

29 November 2017

Masami Arai

4

1 reference

29 November 2017

Satoru Kaneko

5

1 reference

29 November 2017

Makoto Yamashita

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

29 November 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

29 November 2017

volume

12

1 reference

29 November 2017

issue

15

1 reference

29 November 2017

page(s)

1925-1928

1 reference

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900329-3

7 January 2021

10.1016/S0960-894X(02)00329-3

Identifiers

DOI

1 reference

29 November 2017

1 reference